West Virginia 2023 Regular Session

West Virginia Senate Bill SB195

Introduced
1/13/23  
Refer
1/13/23  
Refer
2/8/23  
Engrossed
2/23/23  
Refer
2/23/23  

Caption

Glucagon for Schools Act

Impact

The implementation of SB195 is expected to significantly improve the health management of students with diabetes in educational settings. By ensuring that glucagon is readily accessible and can be administered by trained staff, schools are adopting a proactive approach to student health. This act not only mandates training for school personnel but also promotes awareness of diabetic-related emergencies, allowing for quicker and potentially life-saving interventions when necessary.

Summary

Senate Bill 195, known as the Glucagon for Schools Act, establishes a framework for schools in West Virginia to maintain and administer undesignated glucagon for students experiencing severe hypoglycemic reactions. The bill allows licensed healthcare providers to prescribe glucagon in the name of a school district, facilitating schools to keep a supply ready for emergencies. Trained school personnel are authorized to administer this medication when a student's prescribed glucagon is unavailable or expired, thereby enhancing the immediate response capabilities for students with diabetes.

Sentiment

The sentiment surrounding SB195 has been largely positive, with support from various stakeholders, including healthcare providers and educators who recognize the importance of safeguarding the health of diabetic students. The legislation has garnered bipartisan support, highlighting a commitment to student safety and well-being. However, there is an undercurrent of debate regarding the training and readiness of all school personnel, with some advocating for more extensive training programs to ensure complete preparedness in emergency situations.

Contention

While the bill protects school personnel from liability when administering glucagon in good faith, there are concerns about the adequacy of training and the implications for accountability. Critics point out the challenges in implementing consistent training across all schools, especially in rural areas where resources may be limited. The need for clear guidelines and comprehensive training remains a significant point of contention among educators, healthcare professionals, and parent advocacy groups.

Companion Bills

No companion bills found.

Previously Filed As

WV SB92

Glucagon for Schools Act

WV SB293

Creating the Glucagon for Schools Act

WV LD867

An Act Regarding Undesignated Ready-to-use Glucagon Rescue Therapies in Schools

WV H671

Relative to undesignated glucagon rescue therapies in schools

WV H556

Relative to undesignated glucagon rescue therapies in schools

WV SB447

Ready-to-use glucagon rescue therapies in schools.

WV AB450

Ready-to-use glucagon rescue therapies in schools.

WV HB295

AN ACT relating to undesignated glucagon.

WV HB438

AN ACT relating to undesignated glucagon.

WV A5066

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

Similar Bills

WV SB92

Glucagon for Schools Act

WV SB293

Creating the Glucagon for Schools Act

WI SB447

Ready-to-use glucagon rescue therapies in schools.

WI AB450

Ready-to-use glucagon rescue therapies in schools.

MA H556

Relative to undesignated glucagon rescue therapies in schools

MA H671

Relative to undesignated glucagon rescue therapies in schools

ME LD867

An Act Regarding Undesignated Ready-to-use Glucagon Rescue Therapies in Schools

FL H0597

Diabetes Management in Schools